drugset / Trial / NCT01425632
A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis
RandomizedParallel-groupTriple-blindTreatment
Summary
The objectives of this study are: to confirm the superiority of TAU-284 over placebo after two weeks of administration to pediatric patients with perennial allergic rhinitis, and to investigate the dose response, safety, and plasma concentrations of TAU-284.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bepotastine | Small molecule | 10 mg | — |
| Subject | Bepotastine | Small molecule | 20 mg | — |